What you missed this week on Contemporary OB/GYN

Article

It was a very busy week for the Contemporary OB/GYN team.

This week’s top articles included:

Hormonal contraception for women with hypertension

Although hypertension is a modifiable risk factor for cardiovascular disease (CVD), certain hormonal contraceptives increase the risk of stroke and myocardial infarction in women with the disorder.

Effect on endometriosis recurrence with postoperative hormonal suppression

“As surgeons, our primary goal is to make patients feel better and we often accomplish this by surgically treating endometriosis,” said co-author Ally Murji, MD, MPH, an associate professor of ob/gyn at the University of Toronto and Mount Sinai Hospital in Toronto, Canada.

Placental DNA may predict pregnancy complications

New research suggests that placental DNA may have potential as a biomarker for adverse pregnancy outcomes (APOs).

COVID-19 Pregnancy Data in the United States: October 16 Update

Our weekly update of COVID-19 Pregnancy Data, collected by the Centers for Disease Control and Prevention (CDC), totals 26,364 cases, 45 deaths, and 6,011 hospitalizations.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.